More providers sign on to CommonWell

Three more providers have signed on to use CommonWell Health Alliance services to assist with their interoperability efforts.

Fisher-Titus Medical Center in Norwalk, Ohio, Beacon Health System in South Bend Ind., and Circle Health in Lowell, Mass., all operate on Cerner's EHR. 

Fisher-Titus is the first all-digital smart community hospital in the U.S. and includes a 99-bed acute care hospital, Level III trauma center, skilled nursing facility, assisted living, home health center and outpatient services.

Beacon operates Elkhart General Hospital and Memorial Hospital of South Bend, facilities that have been providing care throughout north central Indiana and southwestern Michigan for more than 100 years.

Circle Health operates Lowell General Hospital where CommonWell services will allow individuals using its inpatient and outpatient facilities to give their doctors and nurses access to medical records from outside healthcare organizations that participate in CommonWell.

Services offered by CommonWell include patient identification and linking, record location and retrieval through a virtual table of contents, patient access, privacy and consent management and trusted data access through authentication portals.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.